Colesevelam now included in ACE/AACE guide as combination therapy for glycemic control

The American College of Endocrinologists (ACE) and the American Association of Endocrinologists (AACE) have included colesevelam (Welchol, Daiichi Sankyo), a bile acid sequestrant, as an option for treating patients with Type 2 diabetes in their Road Maps to Achieve Glycemic Control in